Cargando…
Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft Cell Carcinoma
Extrapulmonary neuroendocrine carcinomas (EP-NECs) are associated with a poor clinical outcome, and limited information is available on the biology and treatment of EP-NECs. We studied EP-NECs by applying the recent novel findings from studies of pulmonary neuroendocrine carcinomas, including POU2F3...
Autores principales: | Koh, Jiwon, Kim, Haeryoung, Moon, Kyung Chul, Lee, Cheol, Lee, Kyoungbun, Ryu, Han Suk, Jung, Kyeong Cheon, Jeon, Yoon Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833113/ https://www.ncbi.nlm.nih.gov/pubmed/36253891 http://dx.doi.org/10.1097/PAS.0000000000001977 |
Ejemplares similares
-
Epidemiology and Retrospective Analysis in Extrapulmonary Neuroendocrine Carcinoma
por: Sethi, Ashish, et al.
Publicado: (2021) -
Clinical Overview of Extrapulmonary Small Cell Carcinoma
por: Kim, Kyeong-Ok, et al.
Publicado: (2006) -
A single center’s experience of the extrapulmonary neuroendocrine carcinomas
por: Celik, Emir, et al.
Publicado: (2021) -
Efficacy of topotecan in pretreated metastatic poorly differentiated extrapulmonary neuroendocrine carcinoma
por: Apostolidis, Leonidas, et al.
Publicado: (2016) -
Phase II study of temozolomide monotherapy in patients with extrapulmonary neuroendocrine carcinoma
por: Kobayashi, Noritoshi, et al.
Publicado: (2021)